Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 398,858 | 507,734 | 203,893 | 214,662 | 230,910 |
| Marketable Securities | 47,964 | 3,212 | N/A | 8,114 | 13,454 |
| Receivables | 36,415 | 29,413 | 26,212 | 27,620 | 18,386 |
| Inventories | 16,144 | 15,791 | 13,663 | 9,846 | 5,113 |
| TOTAL | $511,714 | $566,136 | $252,743 | $265,802 | $273,771 |
| Non-Current Assets | |||||
| PPE Net | 8,799 | 8,714 | 7,829 | 7,669 | 7,035 |
| Investments And Advances | 0 | 6,829 | 0 | 0 | 0 |
| Other Non-Current Assets | 7,207 | 6,472 | 5,191 | 3,813 | 3,625 |
| TOTAL | $16,006 | $22,015 | $13,020 | $11,482 | $10,660 |
| Total Assets | $527,720 | $588,151 | $265,763 | $277,284 | $284,431 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,881 | 27,808 | 45,246 | 35,304 | 37,076 |
| Accrued Expenses | 63,584 | 72,670 | 56,308 | 48,765 | 32,719 |
| TOTAL | $81,017 | $103,718 | $133,608 | $115,601 | $101,201 |
| Non-Current Liabilities | |||||
| Long Term Debt | 604,461 | 585,457 | 274,164 | 263,658 | 254,335 |
| Deferred Revenues | 1,471 | 1,421 | 602 | 551 | 405 |
| TOTAL | $610,918 | $591,419 | $279,199 | $267,758 | $258,218 |
| Total Liabilities | $691,935 | $695,137 | $412,807 | $383,359 | $359,419 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 185,584 | 184,662 | 179,936 | 178,870 | 177,697 |
| Common Shares | 1,856 | 1,843 | 1,798 | 1,787 | 1,777 |
| Retained earnings | -1,281,700 | -1,207,504 | -1,189,725 | -1,130,924 | -1,087,726 |
| Other shareholders' equity | 186 | 177 | 114 | 87 | 182 |
| TOTAL | $-164,215 | $-106,986 | $-147,044 | $-106,075 | $-74,988 |
| Total Liabilities And Equity | $527,720 | $588,151 | $265,763 | $277,284 | $284,431 |